<p>Prevalence of infection in the total population (top), women ages over years (bottom left) and men (bottom right) are shown when vaccination is started at year 1 and is given for 999 years. Vaccination levels, from top to bottom, are 0, 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100%. Vaccine efficacy () is assumed to be and the proportion of females by age 12 that are HSV-1 and HSV-2 seronegative () is assumed to be .</p
<p>Estimated HPV 6/11 related incidence of genital warts among females over 100 years, by vaccinatio...
<p>Estimated HPV 16/18 related incidence of CIN 2/3 among females over 100 years, by vaccination sce...
Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, b...
<p>Prevalence of HSV-2 decreases as vaccine uptake increases in the total population (solid line), w...
<p>The prevalence refers to hrHPV prevalence among females 10–70 years of age. Base-case vaccination...
<p>Vaccine coverage was supposed constant in each scenario. In parentheses, % of reduction in HPV pr...
<p>Unless otherwise stated, the results pertain to females under the base-case scenario. (a) The mod...
<p>Totals may be slightly different due to rounding. Prevalence (and corresponding numbers infected)...
<p>Infection includes both transient and persistent infections (Pers.inf.). The prevalence refers to...
<p>Totals may be slightly different due to rounding. Sex-specific estimates for Africa, Eastern Medi...
Genital Herpes, which is caused by Herpes Simplex Virus-1 or-2 (HSV-1,-2, predominantly HSV-2) is a ...
<div><p>Genital Herpes, which is caused by Herpes Simplex Virus-1 or -2 (HSV-1, -2, predominantly HS...
Genital Herpes, which is caused by Herpes Simplex Virus-1 or -2 (HSV-1, -2, predominantly HSV-2) is ...
Genital Herpes, which is caused by Herpes Simplex Virus-1 or -2 (HSV-1, -2, predominantly HSV-2) is ...
<p>Frequency of HBV infection and chronic infection in 2008, by age group and village, among all vac...
<p>Estimated HPV 6/11 related incidence of genital warts among females over 100 years, by vaccinatio...
<p>Estimated HPV 16/18 related incidence of CIN 2/3 among females over 100 years, by vaccination sce...
Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, b...
<p>Prevalence of HSV-2 decreases as vaccine uptake increases in the total population (solid line), w...
<p>The prevalence refers to hrHPV prevalence among females 10–70 years of age. Base-case vaccination...
<p>Vaccine coverage was supposed constant in each scenario. In parentheses, % of reduction in HPV pr...
<p>Unless otherwise stated, the results pertain to females under the base-case scenario. (a) The mod...
<p>Totals may be slightly different due to rounding. Prevalence (and corresponding numbers infected)...
<p>Infection includes both transient and persistent infections (Pers.inf.). The prevalence refers to...
<p>Totals may be slightly different due to rounding. Sex-specific estimates for Africa, Eastern Medi...
Genital Herpes, which is caused by Herpes Simplex Virus-1 or-2 (HSV-1,-2, predominantly HSV-2) is a ...
<div><p>Genital Herpes, which is caused by Herpes Simplex Virus-1 or -2 (HSV-1, -2, predominantly HS...
Genital Herpes, which is caused by Herpes Simplex Virus-1 or -2 (HSV-1, -2, predominantly HSV-2) is ...
Genital Herpes, which is caused by Herpes Simplex Virus-1 or -2 (HSV-1, -2, predominantly HSV-2) is ...
<p>Frequency of HBV infection and chronic infection in 2008, by age group and village, among all vac...
<p>Estimated HPV 6/11 related incidence of genital warts among females over 100 years, by vaccinatio...
<p>Estimated HPV 16/18 related incidence of CIN 2/3 among females over 100 years, by vaccination sce...
Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, b...